Evangelos Giampazolias Cancer Research UK Manchester Institute United Kingdom

Evangelos Giampazolias earned his BSc in Chemistry(2009) and MSc in Clinical Biochemistry(2012) from the University of Athens. He completed his PhD at CRUK Beatson Institute under Professor Stephen Tait, linking mitochondria-regulated cell death to cancer immunity; recognised with the Institute of Cancer Sciences(2017) and CRUK Pontecorvo (2018) Prizes. As a Postdoctoral Fellow with Professor Caetano Reis e Sousa at the Francis Crick Institute, he studied how dendritic cells couple dying tumour cells to cancer immunity. In 2023, he established the Cancer Immunosurveillance Group at CRUK Manchester Institute, where his signature work investigates nutrient-host-microbiome interactions shaping cancer immunity, advanced by his 2024 ERC Starting Grant. He is Academic Lead for the microbiome workflow of the MRC-funded RISE and MANIFEST consortia in immuno-oncology. He filed two patent applications for novel immunotherapies and was recognised with the BACR/AstraZeneca Frank Rose Award(2025).

Wednesday 10 June 2026

Time	Session

11:35 13:10	Symposium: Microbiome Marisol S.Soengas Chair Spanish National Cancer Research Center (CNIO)Spain Decoding host-microbiome interactions in cancer immunity. Killing cancer with a gut instinct EvangelosGiampazolias Speaker Cancer Research UK Manchester InstituteUnited Kingdom Proffered Paper: Intra-tumoral microbiota and host genotype cooperatively shape neutrophil cytotoxic functions in patients with colorectal cancer EACR26-0130 EACR26-0130 ElisaSorrenti Oral Presenter Università della Svizzera ItalianaSwitzerland The microbiota in cancer treatment efficacy MariaRescigno Speaker CeMMAustria Proffered Paper: Immune Checkpoint Inhibitor Therapy Efficacy and Toxicity Is Associated with Distinct Gut Microbiome–Driven Inflammatory Profiles EACR26-1103 EACR26-1103 Merelvan Gogh Oral Presenter UMC UtrechtNetherlands Covalent targeting of the proteasome regulator PSME4 reprograms tumor inflammation (REMOTE PRESENTATION) YifatMerbl Speaker The Merbl LabIsrael Room F1+2+3

Time

Session

11:35

13:10

Symposium: Microbiome

Marisol S.Soengas Chair Spanish National Cancer Research Center (CNIO)Spain

Decoding host-microbiome interactions in cancer immunity. Killing cancer with a gut instinct

EvangelosGiampazolias Speaker Cancer Research UK Manchester InstituteUnited Kingdom
Proffered Paper: Intra-tumoral microbiota and host genotype cooperatively shape neutrophil cytotoxic functions in patients with colorectal cancer

EACR26-0130

EACR26-0130

ElisaSorrenti Oral Presenter Università della Svizzera ItalianaSwitzerland
The microbiota in cancer treatment efficacy

MariaRescigno Speaker CeMMAustria
Proffered Paper: Immune Checkpoint Inhibitor Therapy Efficacy and Toxicity Is Associated with Distinct Gut Microbiome–Driven Inflammatory Profiles

EACR26-1103

EACR26-1103

Merelvan Gogh Oral Presenter UMC UtrechtNetherlands
Covalent targeting of the proteasome regulator PSME4 reprograms tumor inflammation (REMOTE PRESENTATION)

YifatMerbl Speaker The Merbl LabIsrael

Room F1+2+3